Get started
Author

Linda M. Gorgos

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19
2022 · Anil Gupta, Yaneicy Gonzalez-Rojas, et al. · JAMA · 279
PDF
Sexually Transmitted Infections Among Women Who Have Sex With Women
2011 · Linda M. Gorgos, Jeanne M. Marrazzo · Clinical Infectious Diseases · 83
Emerging Sexual Health Issues Among Women Who Have Sex with Women
2012 · Jeanne M. Marrazzo, Linda M. Gorgos · Current Infectious Disease Reports · 64
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study
2024 · Joseph J Eron, Susan J Little, et al. · The Lancet HIV · 49
PDF
Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis
2015 · Linda M. Gorgos, Laura K. Sycuro, et al. · Sexually Transmitted Diseases · 42
Sexual Transmission of Viral Hepatitis
2013 · Linda Gorgos · Infectious Disease Clinics of North America · 33
Heteroatom-facilitated ortho-directed lithiations of 2-arylimidazoles
1992 · Thomas P. Demuth, David C. Lever, et al. · The Journal of Organic Chemistry · 14
Chlamydia Positivity in American Indian/Alaska Native Women Screened in Family Planning Clinics, 1997–2004
2008 · Linda Gorgos, David Fine, et al. · Sexually Transmitted Diseases · 13
Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab
2025 · Joseph J Eron, Paul P Cook, et al. · The Journal of Infectious Diseases · 11
Determinants of Survival for Native American Adults with HIV Infection
2006 · Linda Gorgos, Erica Avery, et al. · AIDS Patient Care and STDs · 10
Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 study
2026 · Onyema Ogbuagu, Aditya Gaur, et al. · The Lancet Microbe · 9
Gonorrhoea positivity among women aged 15-24 years in the USA, 2005-2007
2011 · L. Gorgos, L. Newman, et al. · Sexually Transmitted Infections · 8
Switch to single-tablet bictegravir–lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial
2026 · Chloe Orkin, Chloe Orkin, et al. · The Lancet · 5
STIs Among Women Who Have Sex with Women
2017 · Linda Gorgos, Jeanne Marrazzo · Springer eBooks · 5
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
2026 · Amy E Colson, Princy N Kumar, et al. · The Lancet · 3
15: Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis
2015 · L. Sycuro, L. Gorgos, et al. · American Journal of Obstetrics and Gynecology · 1
Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
2026 · Eric G Meissner, Eric G Meissner, et al. · The Lancet HIV
P-365. Pooled safety and tolerability of twice-yearly lenacapavir with teropavimab and zinlirvimab for HIV-1 treatment
2026 · Kimberly Workowski, Peter Ruane, et al. · Open Forum Infectious Diseases
Efficacité et sécurité de l'association Lenacapavir plus bNAbs chez les PVVIH pour les sensibles au téropavimab ou au zinlirvimab
2024 · Joseph J. Eron, Paul P. Cook, et al. · Médecine et Maladies Infectieuses Formation
ChemInform Abstract: Heteroatom‐Facilitated Ortho‐Directed Lithiations of 2‐Arylimidazoles.
1992 · T. P. JUN. DEMUTH, D. C. LEVER, et al. · ChemInform
Works count: 20
Citation count: 629
H-index: 10
I10-index: 10
Year
Topic
Type